TA TABLE OF CONTENT
SS S S
Chapter 1: Pharmacokinetics
S S
Chapter 2: Drug– S S
Receptor Interactions and Pharmacodynamics Chapter 3: The Autonomic Nervous System
S S S S S S S S S
Chapter 4: Cholinergic Agonists Chapter 5: Cholinergic Antagonists Cha
S S S S S S S S
pter 6: Adrenergic Agonists Chapter 7: Adrenergic Antagonists
S S S S S S S
Chapter 8: Drugs for Neurodegenerative Diseases Chapter 9: Anxiolytic and Hypnotic Drug
S S S S S S S S S S S
s
Chapter 10: Antidepressants Chapter 11: Antipsychotic Drugs Chapter 1
S S S S S S S S
2: Drugs for Epilepsy Chapter 13: Anesthetics
S S S S S S
Chapter 14: Opioids
S S
Chapter 15: Drugs of Abuse Chapter 16: CNS Stimulants Chapter 17: An
S S S S S S S S S S S
tihypertensives Chapter 18: Diuretics S S S
Chapter 19: Heart Failure
S S S
Chapter 20: Antiarrhythmics Chapter 21: Antianginal Drugs
S S S S S S
Chapter 22: Anticoagulants and Antiplatelet Agents Chapter 23: Drugs for Hyperlipidemia
S S S S S S S S S S
Chapter 24: Pituitary and Thyroid Chapter 25: Drugs for Diabetes
S S S S S S S S S
Chapter 26: Estrogens and Androgens Chapter 27: Adrenal Hormones
S S S S S S S S
Chapter 28: Drugs for Obesity
S S S S
Chapter 29: Drugs for Disorders of the Respiratory System Chapter 30: Antihistamines
S S S S S S S S S S S
Chapter 31: Gastrointestinal and Antiemetic Drugs Chapter 32: Drugs for Urologic Disorde
S S S S S S S S S S S
rs
Chapter 33: Drugs for Anemia
S S S S
Chapter 34: Drugs for Dermatologic Disorders Chapter 35: Drugs for Bone Disorders
S S S S S S S S S S S
Chapter 36: Anti-S S
inflammatory, Antipyretic, and Analgesic Agents Chapter 37: Principles of Antimicrobial Therapy
S S S S S S S S S S
Chapter 38: Cell Wall Inhibitors
S S S S
Chapter 39: Protein Synthesis Inhibitors
S S S S
Chapter 40: Quinolones, Folic Acid Antagonists, and Urinary Tract Antiseptics Chapter 41: Antimycobacterial Drugs
S S S S S S S S S S S S S
Chapter 42: Antifungal Drugs Chapter 43: Antiprotozoal Drugs Chapter
S S S S S S S S S
44: Anthelmintic Drugs Chapter 45: Antiviral Drugs
S S S S S S
Chapter 46: Anticancer Drugs
S S S
Chapter 47: Immunosuppressants Chapter 48: Clinical Toxicology
S S S S S S
Page 2 of 507
,Page 3 of 507
,3. The nurse is teaching a patient who will be discharged home with a prescription for an enteric-
T T T T T T T T T T T T T T T T
coated tablet. Which statement by the patient indicates understanding of the teaching?
T T T T T T T T T T T T
a. I may crush the tablet and put it in applesauce to improve absorption.
T T T T T T T T T T T T
b. I should consume acidic foods to enhance absorption of this medication.
T T T T T T T T T T
c. I should expect a delay in onset of the drugs effects after taking the tablet.
T T T T T T T T T T T T T T
d. I should take this medication with high-
T T T T T T
fat foods to improve its action. ANS: C
T T T T T T T
Enteric-
coated tablets resist disintegration in the acidic environment of the stomach and disintegrate when t
T T T T T T T T T T T T T T
hey reach the small intestine. There is usually some delay in onset of actions after taking these medic
T T T T T T T T T T T T T T T T T
ations. Enteric- T
coated tablets should not be crushed or chewed, which would alter the time and location of absorptio
T T T T T T T T T T T T T T T T
n. Acidic foods will not enhance the absorption of the medication. The patient should not to eat high
T T T T T T T T T T T T T T T T T
-fat food before ingesting an enteric-coated tablet, because high-
T T T T T T T T
fat foods decrease the absorption rate.
T T T T T
DIF: COGNITIVE LEVEL: Applying (Application) REF: dm 3 TOP
T T T T T T T T
: NURSING PROCESS: Nursing Intervention
T T T T
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
T T T T T T T
4. A patient who is newly diagnosed with type 1 diabetes mellitus asks why insulin must be given b
T T T T T T T T T T T T T T T T T
y subcutaneous injection instead of by mouth. The nurse will explain that this is because
T T T T T T T T T T T T T T
a. absorption is diminished by the first-pass effects in the liver. T T T T T T T T T
b. absorption is faster when insulin is given subcutaneously. T T T T T T T
c. digestive enzymes in the gastrointestinal tract prevent absorption. T T T T T T T
d. the oral form is less predictable with more adverse effects. A
T T T T T T T T T T
NS: C T
Page 4 of 507
, Insulin, growth hormones, and other protein-
T T T T T
based drugs are destroyed in the small intestine by digestive enzymes and must be given parenterall
T T T T T T T T T T T T T T T
y. Because insulin is destroyed by digestive enzymes, it would not make it to the liver for metabolis
T T T T T T T T T T T T T T T T T
m with a first-
T T T
pass effect. Subcutaneous tissue has fewer blood vessels, so absorption is slower in such tissue. Insu
T T T T T T T T T T T T T T T
lin is given subcutaneously because it is desirable to have it absorb slowly.
T T T T T T T T T T T T
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3 TO
T T T T T T T T
P: NURSING PROCESS: Nursing Intervention: Patient Teaching
T T T T T T
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
T T T T T T T
Page 5 of 507